ArticleNature communications2025

A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously.

Shupei Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.